Literature DB >> 17959239

Non-inferiority trials are unethical because they disregard patients' interests.

Silvio Garattini1, Vittorio Bertele'.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17959239     DOI： 10.1016/S0140-6736(07)61604-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  39 in total

Review 1.  Generic and therapeutic substitutions: are they always ethical in their own terms?

Authors:  Mubarak AlAmeri; Miran Epstein; Atholl Johnston
Journal:  Pharm World Sci       Date:  2010-12

2.  EMA's reflection on placebo does not reflect patients' interests.

Authors:  Vittorio Bertele'; Rita Banzi; Christian Gluud; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2011-12-02       Impact factor: 2.953

Review 3.  Do we learn the right things from clinical trials?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953

Review 4.  Recent national and regional drug reforms in Sweden: implications for pharmaceutical companies in Europe.

Authors:  Björn Wettermark; Brian Godman; Karolina Andersson; Lars L Gustafsson; Alan Haycox; Vittorio Bertele
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  Noninferiority trials: clinical understandings and misunderstandings.

Authors:  John H Powers; Thomas R Fleming
Journal:  Clin Investig (Lond)       Date:  2013-03-01

Review 6.  Use of Mortality as an Endpoint in Noninferiority Trials May Lead to Ethically Problematic Conclusions.

Authors:  Andrew M Hersh; Robert J Walter; Scott K Abberegg
Journal:  J Gen Intern Med       Date:  2019-02-12       Impact factor: 5.128

7.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

8.  Thrombolysis or nothing for acute myocardial infarction? It's all the same!

Authors:  Vittorio Bertele'; Laura Angelici; Simona Barlera; Silvio Garattini
Journal:  Br J Clin Pharmacol       Date:  2008-04-01       Impact factor: 4.335

Review 9.  Issues in noninferiority trials: the evidence in community-acquired pneumonia.

Authors:  Thomas R Fleming; John H Powers
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

Review 10.  Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

Authors:  Grace Wangge; Olaf H Klungel; Kit C B Roes; Anthonius de Boer; Arno W Hoes; Mirjam J Knol
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.